PRAXIS PRECISION MEDICINES, INC. Other Non-Current Assets
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Other Non-Current Assets of $643.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $643.00K.
- 2025-12-31: Other Assets, Noncurrent $0.00.
- 2025-09-30: Other Assets, Noncurrent $0.00.
- 2025-06-30: Other Assets, Noncurrent $0.00.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $643.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $416.00K 10-K · filed 2026-02-19 | |
| 2024-09-30 | $416.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $416.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $416.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $416.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $416.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $416.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $416.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $416.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $416.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $416.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $416.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $472.00K 10-K · filed 2023-02-07 | |
| 2021-09-30 | $416.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $496.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $9.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $15.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | $2.07M 10-Q · filed 2020-11-23 | |
| 2019-12-31 | $620.00K 10-K · filed 2021-03-17 | $20.00K 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |